<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00469729</url>
  </required_header>
  <id_info>
    <org_study_id>GC P#02.01.001</org_study_id>
    <nct_id>NCT00469729</nct_id>
    <nct_alias>NCT00763334</nct_alias>
  </id_info>
  <brief_title>Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy</brief_title>
  <acronym>ExCell</acronym>
  <official_title>A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gamida Cell -Teva Joint Venture Ltd.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gamida Cell -Teva Joint Venture Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of transplanting StemEx® in
      patients with certain hematological malignancies. For these patients, it is suggested that
      StemEx® can improve upon the outcome of transplanting a single, unmanipulated cord blood unit
      by significantly increasing the number of stem/progenitor cells available to the patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Allogeneic hematopoietic stem cell transplantation is a life-saving procedure for patients
      with hematologic malignancies; yet wide application of this procedure is limited by the
      availability of suitably Human Leukocyte Antigen (HLA) - matched donors. Only 30% of patients
      who could benefit from this procedure have an HLA-matched sibling. The lengthy search for a
      matched donor may critically delay transplantation. In addition, far fewer patients of racial
      minorities find suitable HLA-matched donors. Umbilical cord blood (UCB) has been increasingly
      used as an alternative source of stem cells; however, its use in adults and adolescent
      patients is limited due to insufficient cell dose required for satisfactory hematopoietic
      reconstitution.

      Gamida Cell - Teva Joint Venture Ltd. is engaged in the development of StemEx®, an expanded
      hematopoietic UCB stem cell graft, as a potential medicinal product for the treatment of
      cancer and hematological malignancies. The expansion technology enables preferential
      expansion of hematopoietic stem and early progenitor cells and is based on the findings that
      copper chelators can regulate the balance between self-renewal and differentiation of stem
      cells.

      The multi-national, multi-center Phase II/III clinical study designated to evaluate the
      safety and efficacy of StemEx® will enroll approximately 100 subjects with high-risk
      hematologic malignancies who are candidates for allogeneic stem cell transplantation (SCT).
      This study will evaluate the effect of StemEx® on overall survival as measured by overall
      100-day mortality.

      The study consists of 4 phases:

        1. Screening phase includes subjects' clinical assessment and screening tests

        2. Conditioning phase includes the myeloablative treatment prior transplantation procedure

        3. Transplantation and post-transplant follow-up phase to day 180

        4. Observational phase: survival status follow-up to day 730 (18 months)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall 100-day mortality</measure>
    <time_frame>100 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>180 day mortality, acute Graft versus Host Disease (GvHD) grades III-IV, engraftment failure</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability measures: The incidence and frequency of adverse experiences, acute toxicity, laboratory data and vital signs follow-up.</measure>
    <time_frame>180 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of overall mortality at 1 year</measure>
    <time_frame>One year post transplant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of overall mortality at 2 years</measure>
    <time_frame>Two years post transplant</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Hematologic Malignancies</condition>
  <condition>Acute Myeloid Leukemia</condition>
  <condition>Lymphoid Leukemia</condition>
  <condition>Chronic Myeloid Leukemia</condition>
  <condition>Hodgkin's Disease</condition>
  <condition>Non-Hodgkin's Lymphoma</condition>
  <condition>Myelodysplastic Syndromes</condition>
  <arm_group>
    <arm_group_label>StemEx</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>StemEx®</intervention_name>
    <description>The stem/progenitor cell based product composed of ex vivo expanded allogeneic umbilical cord blood cells, which is infused to subject at a rate of 1-3 ml/min in combination with non-manipulated cells derived from the same cord blood unit.</description>
    <arm_group_label>StemEx</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical diagnosis of AML or ALL: CR2 or subsequent complete remission (CR) or CR1
             with high-risk features or relapse with &lt; 10% blasts in BM and no circulating blasts.

          2. Clinical diagnosis of CML: in CP1 (Chronic Phase 1) and resistant or intolerant to
             Gleevec or in CP2 or subsequent CP or in accelerated phase.

          3. Clinical diagnosis of HD: induction failure or relapse and sensitive to last
             chemotherapy course.

          4. Clinical diagnosis of NHL induction failure or relapse and sensitive to last
             chemotherapy course.

          5. Clinical diagnosis of MDS with intermediate 2- or high-risk IPSS score.

        Exclusion Criteria:

          1. Less than twenty-one days have elapsed since the subject's last radiation or
             chemotherapy prior to conditioning (except Hydroxyurea).

          2. HIV positive.

          3. Pregnancy or lactation.

          4. Uncontrolled bacterial, fungal or viral infection.

          5. Subjects with signs and symptoms of active central nervous system (CNS) disease.

          6. Availability of appropriate related and willing stem cell donor, who is HLA-matched at
             5 or 6/6 antigens.

          7. Prior allogeneic cell transplant.

          8. Allergy to bovine or to any product, which may interfere with the treatment.

          9. Enrolled in another clinical trial or received an investigational treatment during the
             last 30 days, unless approved by Sponsor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ka Wah Chan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Transplant Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott D Rowley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cancer Center at Hackensack University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Territo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCLA Oncology Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Stiff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University Cardinal Bernardin Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Agha Mounzer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh Cancer Institute/UPMC Cancer Centers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Entezam Sahovic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Western Pennsylvania Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Celia Grosskreutz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Giller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Children's Hospital, B115, University of Colorado Health Sciences Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Neudorf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children’s Hospital of Orange County</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ronit Yerushalmi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaim Sheba Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tsila Zuckerman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christelle Ferra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germans Trias i Pujol Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina Arbona, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clínico Universitario de Valencia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guillermo Sanz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Fe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Arcese, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universita di Roma Tor Vergata</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Bosi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale di Careggi BMT Unit Department of Haematology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sonali Chaudhury, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorge Sierra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Igor B. Resnick, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Bone Marrow Transplantation And Cancer Immunotherapy Hebrew University Hospital Ein-Karem, Jerusalem</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Franco Locatelli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Pedriatrico Bambino Gesù</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Mi Kwon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Marañón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Pere Barba, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Vall d´Hebrón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Cristina Diaz de Heredia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Vall d´Hebrón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Mary J Laughlin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hematopoietic Stem Cell Transplant Program, University of Virginia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCLA's Jonsson Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095-1781</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868-3874</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital, B115, University of Colorado Health Sciences Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cancer Center at Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cornell University, Joan &amp; Sanford I. Weill Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>NY 10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Steven and Alexandra Cohen Children's Medical Center of New York</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>One Gustave L Levy Place, BOX 1410, New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Western Pennsylvania Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Cancer Institute/UPMC Cancer Centers</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Transplant Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia, Hematopoietic Stem Cell Transplant Program</name>
      <address>
        <city>West Complex 1300 Jefferson Park Av, Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin Division of Neoplastic Diseases and Related Disorders</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin Pediatric Blood and Marrow Transplant Program</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szent Laszlo &amp; Szent Istvan Hospital</name>
      <address>
        <city>Budapest</city>
        <zip>1097</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hebrew University Hospital Ein-Karem, Department of Bone Marrow Transplantation And Cancer Immunotherapy</name>
      <address>
        <city>Jerusalem</city>
        <zip>P.O.B 12000</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>PO Box 9602, Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Pedriatrico Bambino Gesù</name>
      <address>
        <city>Roma</city>
        <zip>00165</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universita di Roma Tor Vergata</name>
      <address>
        <city>via Oxford 81, Roma</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Careggi BMT Unit Department of Haematology</name>
      <address>
        <city>Viale Morgagni, Florence</city>
        <zip>85 - 50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Avda. Blasco Ibañez, 17, Valencia</city>
        <state>Comunidad Valenciana</state>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe</name>
      <address>
        <city>Av Campanar 21, Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>C/ Sant Antoni Maria Claret, Barselona</city>
        <zip>167 - 08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Carretera de Canyet s/n, Badalona</city>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Doctor Esquerdo 46 , Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d´Hebrón (Pediatrics)</name>
      <address>
        <city>Passeig de la Vall d´Hebrón 119-129, Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d´Hebrón</name>
      <address>
        <city>Passeig de la Vall d´Hebrón 119-129, Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <link>
    <url>http://www.gamida-cell.com/</url>
    <description>Sponsor's website</description>
  </link>
  <link>
    <url>http://www.lymphomation.org</url>
    <description>Patients Against Lymphoma</description>
  </link>
  <link>
    <url>http://www.bmtinfonet.org/</url>
    <description>Bone and Marrow Transplant Information Network</description>
  </link>
  <link>
    <url>http://www.cancer.gov/cancertopics/types/leukemia</url>
    <description>NCI Leukemia Homepage</description>
  </link>
  <link>
    <url>http://www.medicinenet.com/leukemia/article.htm</url>
    <description>Leukemia information on MediciNet.com</description>
  </link>
  <link>
    <url>http://www.asbmt.org/</url>
    <description>American Society for Blood and Marrow Transplantation</description>
  </link>
  <link>
    <url>http://www.hematology.org/</url>
    <description>American Society of Hematology</description>
  </link>
  <link>
    <url>http://www.lymphoma.org</url>
    <description>Lymphoma Research Foundation</description>
  </link>
  <link>
    <url>http://www.cancer.org/docroot/home/index.asp</url>
    <description>American Cancer Society website</description>
  </link>
  <link>
    <url>http://www.cordbloodforum.org/</url>
    <description>Cord Blood Forum</description>
  </link>
  <link>
    <url>http://www.cibmtr.org/</url>
    <description>Center for International Blood and Marrow Transplant Research</description>
  </link>
  <link>
    <url>http://www.marrow.org/</url>
    <description>National Marrow Donor Program</description>
  </link>
  <link>
    <url>http://www.choc.org/</url>
    <description>Children's Hospital of Orange County</description>
  </link>
  <link>
    <url>http://www.ucdenver.edu/academics/colleges/medicalschool/centers/cancercenter/Pages/CancerCenter.aspx</url>
    <description>University of Colorado Cancer Center</description>
  </link>
  <link>
    <url>http://www.childrensmemorial.org/depts/stemcell/overview.aspx</url>
    <description>Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital website</description>
  </link>
  <link>
    <url>http://www.luhs.org/svcline/cancer/index.cfm</url>
    <description>Cardinal Bernadin Cancer Center</description>
  </link>
  <link>
    <url>http://www.cumc.columbia.edu/dept/ps/</url>
    <description>Columbia University College of Physicians and Surgeons</description>
  </link>
  <link>
    <url>http://www.mountsinai.org/</url>
    <description>Mount Sinai Medical Center</description>
  </link>
  <link>
    <url>http://medschool.duke.edu/</url>
    <description>Duke University Medical Center</description>
  </link>
  <link>
    <url>http://www.case.edu/</url>
    <description>Case Western Reserve University</description>
  </link>
  <link>
    <url>http://www.upmccancercenters.com/</url>
    <description>University of Pittsburgh Cancer Institute</description>
  </link>
  <link>
    <url>http://www.wpahs.org/wph/</url>
    <description>The Western Pennsylvania Hospital</description>
  </link>
  <link>
    <url>http://www.mdanderson.org/</url>
    <description>MD Anderson Cancer Center</description>
  </link>
  <link>
    <url>http://www.texastransplant.org/</url>
    <description>Texas Transplant Institute</description>
  </link>
  <link>
    <url>http://www.chu-stlouis.fr/</url>
    <description>Hôpital Saint Louis</description>
  </link>
  <link>
    <url>http://eng.sheba.co.il/</url>
    <description>Chaim Sheba Medical Center</description>
  </link>
  <link>
    <url>http://www.rambam.org.il/</url>
    <description>Rambam Medical Center</description>
  </link>
  <link>
    <url>http://web.uniroma2.it/home.php?sr=1024</url>
    <description>Universita di Roma Tor Vergata</description>
  </link>
  <link>
    <url>http://www.aou-careggi.toscana.it/internet/index.php</url>
    <description>Ospedale di Careggi BMT Unit Department of Haematology</description>
  </link>
  <link>
    <url>http://www.gencat.net/ics/germanstrias/</url>
    <description>Hospital Germans Trias i Pujol</description>
  </link>
  <link>
    <url>http://www.hospitalclinic.org/</url>
    <description>Hospital Clinic of Barcelona</description>
  </link>
  <link>
    <url>http://www.santpau.es/</url>
    <description>Hospital de la Santa Creu i Sant Pau</description>
  </link>
  <link>
    <url>http://www.ucla.edu/</url>
    <description>ULCA</description>
  </link>
  <reference>
    <citation>Peled T, Landau E, Prus E, Treves AJ, Nagler A, Fibach E. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol. 2002 Mar;116(3):655-61. Erratum in: Br J Haematol 2002 May;117(2):485.</citation>
    <PMID>11849228</PMID>
  </reference>
  <reference>
    <citation>Peled T, Landau E, Mandel J, Glukhman E, Goudsmid NR, Nagler A, Fibach E. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol. 2004 Jun;32(6):547-55.</citation>
    <PMID>15183895</PMID>
  </reference>
  <reference>
    <citation>Prus E, Peled T, Fibach E. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells. Leuk Lymphoma. 2004 Mar;45(3):583-9.</citation>
    <PMID>15160922</PMID>
  </reference>
  <reference>
    <citation>Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, Austin M, Hasson A, Fibach E, Shpall EJ, Nagler A. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy. 2004;6(4):344-55.</citation>
    <PMID>16146887</PMID>
  </reference>
  <reference>
    <citation>Peled T, Glukhman E, Hasson N, Adi S, Assor H, Yudin D, Landor C, Mandel J, Landau E, Prus E, Nagler A, Fibach E. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells. Exp Hematol. 2005 Oct;33(10):1092-100.</citation>
    <PMID>16219531</PMID>
  </reference>
  <reference>
    <citation>Shpall EJ, M.d.L., K. Chan, R. Champlin, A. Gee, P. Thall, K. Komanduri, D. Couriel, C. Hosing, B. Andersson, R. Jones, S. Giralt, S. Karandish, T. Sadeghi, B. Muriera, S. O'Connor, L. Wooten, X. Wang, S. Robinson, P. Fu, J. Wilson, T. Peled, F. Grynspan, A. Nagler, J. McMannis; A Phase I/II Study of Ex Vivo Expanded Cord Blood for Leukemia and Lymphoma. ISCT 2005 - conference publication, 2005.</citation>
  </reference>
  <reference>
    <citation>de Lima M, McMannis J, Gee A, Komanduri K, Couriel D, Andersson BS, Hosing C, Khouri I, Jones R, Champlin R, Karandish S, Sadeghi T, Peled T, Grynspan F, Daniely Y, Nagler A, Shpall EJ. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008 May;41(9):771-8. doi: 10.1038/sj.bmt.1705979. Epub 2008 Jan 21.</citation>
    <PMID>18209724</PMID>
  </reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2007</study_first_submitted>
  <study_first_submitted_qc>May 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2007</study_first_posted>
  <last_update_submitted>July 9, 2015</last_update_submitted>
  <last_update_submitted_qc>July 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tetraethylenepentamine</keyword>
  <keyword>Umbilical Cord Blood Stem Cell Transplantation</keyword>
  <keyword>Hematological Malignancies</keyword>
  <keyword>Acute Lymphoid Leukemia</keyword>
  <keyword>Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Myelodysplastic Syndromes</mesh_term>
    <mesh_term>Preleukemia</mesh_term>
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
    <mesh_term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</mesh_term>
    <mesh_term>Hodgkin Disease</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

